Treatment of End-of-Dose Wearing-Off in Parkinson’s Disease: Stalevo^® (Levodopa/Carbidopa/Entacapone) and Levodopa/DDCI Given in Combination with Comtess^®/Comtan^® (Entacapone) Provide Equivalent Improvements in Symptom Control Superior to That of Traditional Levodopa/DDCI Treatment

By  

European Neurology, Vol. 53, Iss. 4, 2005-07 ,pp. : 197-202

Karger

Access to resources Recommend Favorite

Five-Year Follow-Up of Early Lisuride and Levodopa Combination Therapy versus Levodopa Monotherapy in de novo Parkinson’s Disease

By  

European Neurology, Vol. 44, Iss. 1, 2000-07 ,pp. : 22-30

Karger

Access to resources Recommend Favorite

Single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy

By Vado Antonello   Menardi Endrj   Rossetti Guido   Ballari Gianpaolo   Feola Mauro   Bobbio Marco  

Journal of Interventional Cardiac Electrophysiology, Vol. 39, Iss. 2, 2014-03 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

M.D. Anderson Cancer Center Infusion Therapy Team: A Chronicle of Experience Past, Present & Future

By Richardson Deborah   Caillouet Brenda  

Journal of the Association for Vascular Access, Vol. 9, Iss. 2, 2004-06 ,pp. : 103-108

Association of University Programs in Health Administration

Access to resources Recommend Favorite

Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease

By Riis Åse   Martinsen Tom C.   Waldum Helge L.   Fossmark Reidar  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 6, 2012-06 ,pp. : 649-657

Informa Healthcare

Access to resources Recommend Favorite